About this item
Product details
RYZODEG 70/30 is a soluble insulin product consisting of insulin degludec (ultra-long acting basal insulin) and insulin aspart (rapid acting mealtime insulin) administered in one injection. 1 mL of the solution contains 100 U insulin degludec/insulin aspart (70% soluble insulin degludec and 30% soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 mg salt-free anhydrous insulin aspart. One pre-filled pen or cartridge contains 3 mL, equivalent to 300 U of insulin degludec/insulin aspart. Insulin degludec and insulin apart are produced by recombinant DNA technology in Saccharomyces cerevisiae. Composition 1 mL of the solution contains 100 U insulin degludec/insulin aspart (70% soluble insulin degludec and 30% soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 mg salt-free anhydrous insulin aspart. One pre-filled pen or cartridge contains 3 mL, equivalent to 300 U of insulin degludec/insulin aspart.
- Medicine
- 1 Pre-Filled Pen
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicine
- Brand
- Novo Nordisk
- SKU
- 05712249111557
- Variant
- 1 Pre-Filled Pen
- Tags
- Country:France, Diabetes, Insulin, Medicine, Type 2 Diabetes
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
